NEXGEL Inkomsten in het verleden
Verleden criteriumcontroles 0/6
NEXGEL's earnings have been declining at an average annual rate of -12.5%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 40.8% per year.
Belangrijke informatie
-12.5%
Groei van de winst
70.9%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | 40.8% |
| Rendement op eigen vermogen | -80.0% |
| Nettomarge | -67.6% |
| Volgende winstupdate | 14 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe NEXGEL geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 5 | -3 | 5 | 0 |
| 31 Mar 24 | 5 | -3 | 4 | 0 |
| 31 Dec 23 | 4 | -3 | 4 | 0 |
| 30 Sep 23 | 4 | -3 | 3 | 0 |
| 30 Jun 23 | 3 | -3 | 3 | 0 |
| 31 Mar 23 | 2 | -4 | 3 | 0 |
| 31 Dec 22 | 2 | -5 | 3 | 0 |
| 30 Sep 22 | 2 | -6 | 3 | 0 |
| 30 Jun 22 | 2 | -6 | 3 | 0 |
| 31 Mar 22 | 2 | -5 | 3 | 0 |
| 31 Dec 21 | 2 | -4 | 3 | 0 |
| 30 Sep 21 | 1 | -3 | 2 | 0 |
| 30 Jun 21 | 1 | -3 | 2 | 0 |
| 31 Mar 21 | 1 | -2 | 2 | 0 |
| 31 Dec 20 | 1 | -2 | 2 | 0 |
| 30 Sep 20 | 1 | -2 | 2 | 0 |
| 30 Jun 20 | 1 | -1 | 1 | 0 |
| 31 Mar 20 | 1 | -2 | 2 | 0 |
| 31 Dec 19 | 1 | -2 | 2 | 0 |
| 30 Sep 19 | 1 | -2 | 2 | 0 |
| 30 Jun 19 | 1 | -3 | 3 | 0 |
| 31 Mar 19 | 2 | -2 | 2 | 0 |
| 31 Dec 18 | 2 | -2 | 2 | 0 |
| 30 Sep 18 | 2 | -1 | 2 | 0 |
| 31 Dec 17 | 2 | -1 | 1 | 0 |
| 31 Dec 16 | 2 | -2 | 2 | 0 |
Kwaliteitswinsten: NXGL is currently unprofitable.
Groeiende winstmarge: NXGL is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: NXGL is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.
Versnelling van de groei: Unable to compare NXGL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: NXGL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rendement op eigen vermogen
Hoge ROE: NXGL has a negative Return on Equity (-80.03%), as it is currently unprofitable.